你好,欢迎访问上海交通大学附属第一人民医院公济文库!
所在位置: 首页 - 科室团队导航 - 肿瘤临床医学中心
相关导航
按语种分组
  • 任何
  • 413 中文
  • 372 外文
年代
  • 任何
  • 49 2021
  • 90 2020
  • 60 2019
  • 63 2018
  • 58 2017
  • 45 2016
  • 35 2015
  • 34 2014
  • 18 2013
  • 22 2012
  • 34 2011
  • 18 2010
  • 214 2000-2009
  • 41 1990-1999
按类型分组
  • 任何
  • 366 中文期刊
  • 362 外文期刊
  • 27 中文会议论文
  • 18 中文专利
  • 9 外文专利
  • 更多
按重要期刊分组
  • 任何
  • 315 SCI科学引文索引(美)
  • 261 国内统计源期刊
  • 250 SCIE
  • 213 CSCD中国科学引文库
  • 181 CA化学文摘(美)
  • 更多
按来源刊物分组
  • 任何
  • 23 中国癌症杂志
  • 17 肿瘤
  • 16 中华眼科杂志
  • 13 现代生物医学进展
  • 12 Annals of Onc
  • 更多
科室简介: 成果数量:785

上海交通大学附属第一人民医院肿瘤科是上海市三甲综合医院中最早设立的肿瘤专科,是医院“十二五”期间重点发展的学科之一。2009年,医院整合肿瘤相关学科资源,成立了肿瘤中心,学科带头人黄倩教授,中心主任王理伟教授,肿瘤中心副主任王红霞(兼肿瘤科副主任[主持,南])、刘勇副主任医师,北部执行主任李琦主任医... [详细]

本科室知名学者:
本科室科研趋势: 发文数量 期刊收录
条数据
导出

作者: Yanli Li, Rui Yang, Limo Chen, Sufang Wu (Affiliations 1 Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China. 2 Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009 USA.)

出处: Future oncology (London, England) 2020 Vol.16 No.34 P2853-2861

关键词: CD38;biomarker;cancer immunotherapy;immune checkpoint therapy;immunomodulation;tumor microenvironment.

摘要: CD38 is a transmembrane glycoprotein that is widely expressed in a variety of human tissues and cells, especially those in the immune system. CD38 pro ...

作者: Jiawen Zhang, Qinyi Zhang, Jing Zhang, Qingying Wang (Affiliations 1 Department of Obstetrics and Gynecology, Shanghai Tenth People\'s Hospital, School of Medicine, Tongji University, Shanghai, China. 2 Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, China. 3 Department of Integrated Therapy, Shanghai Cancer Center, Fudan University, Shanghai, China. 4 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.)

出处: DNA and cell biology 2020 Vol.39 No.9 P1545-1557

关键词: ACAP1;cell stemness;immune infiltration;ovarian cancer.

摘要: ADP-ribosylation factor (Arf) GTPase-activating protein (GAP) with coiled-coil, ankyrin repeat and PH domains 1 (ACAP1) is an Arf6 GAP that regulates ...

作者: Chong Li, Lungen Lu, Zhongtian Qi, Yongqiang Zhu, Fengtao Su, Ping Zhao, Hui Dong (Affiliations 1 Cancer Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. 2 Shanghai Key Laboratory of Pancreatic Diseases, Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 3 Department of Microbiology, Second Military Medical University, Shanghai, China. 4 Chinese National Human Genome Center at Shanghai, Shanghai, China.)

出处: Frontiers in microbiology 2020 Vol.11 P535673

关键词: hepatitis C virus;host responses;lipid metabolism;miR-122;miRNome;transcriptome.

摘要: Hepatitis C virus (HCV)-host cell interaction during infection disturbs cellular homeostasis and culminates in pathological consequences. The processe ...

作者: Ye Yuan,Ruonan Bo,Di Jing,Zhao Ma,Zhongling Wang,Tzu-yin Lin,Lijie Dong,Xiangdong Xue,Yuanpei Li (Center for Smart Materials and Devices,State Key Laboratory of Advanced Technology for Materials Synthesis and Processing,Wuhan University of Technology,Wuhan 430070,China;Department of Biochemistry and Molecular Medicine,UC Davis Comprehensive Cancer Center,University of California Davis,Sacramento 95817,USA;Department of Biochemistry and Molecular Medicine,UC Davis Comprehensive Cancer Center,University of California Davis,Sacramento 95817,USA;School of Veterinary Medicine,Yangzhou University,Yangzhou 225009,China;Department of Biochemistry and Molecular Medicine,UC Davis Comprehensive Cancer Center,University of California Davis,Sacramento 95817,USA;Department of Oncology,Xiangya Hospital,Central South University,Changsha 410008,China;Department of Biochemistry and Molecular Medicine,UC Davis Comprehensive Cancer Center,University of California Davis,Sacramento 95817,USA;Department of Biochemistry and Molecular Medicine,UC Davis Comprehensive Cancer Center,University of California Davis,Sacramento 95817,USA;Department of Radiology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200080,China;Division of Hematology/Oncology,Department of Internal Medicine,University of California Davis,Sacramento 95817,USA;Center for Smart Materials and Devices,State Key Laboratory of Advanced Technology for Materials Synthesis and Processing,Wuhan University of Technology,Wuhan 430070,China;Department of Biochemistry and Molecular Medicine,UC Davis Comprehensive Cancer Center,University of California Davis,Sacramento 95817,USA;College of Life Sciences,Northwest University,Xi\'an 710069,China)

出处: 纳米研究(英文版) 2020 第13卷 第2期 P503-510

关键词: PORPHYRIN;7-ethyl-10-hydroxy-camptothecin(SN-38);drug;delivery;self-indication;nanotheranostics;photodynamic;therapy

摘要: Nanotheranostics with comprehensive diagnostic and therapeutic capabilities show exciting cancer treatment potentials.Here,we develop an excipient-fre ...

作者: Rong Jiang, Jianqing Zhu, Jae Weon Kim, Jihong Liu, Kazuyoshi Kato, Hee Seung Kim, Yuqin Zhang, Ping Zhang, Tao Zhu, Daisuke Aoki, Aijun Yu, Xiaojun Chen, Xipeng Wang, Ding Zhu, Wei Zhang, Huixun Jia, Tingyan Shi, Wen Gao, Sheng Yin, Yanling Feng, Libing Xiang, Aikou Okamoto, Rongyu Zang (Affiliations 1 Shanghai Gynecologic Oncology Group and Ovarian Cancer Program, Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China. 2 Shanghai Gynecologic Oncology Group and Department of Gynecologic Oncology, Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China. 3 Korean Gynecologic Oncology Group and Department of Obstetrics and Gynecology, Seoul National University, Seoul, Korea. 4 Shanghai Gynecologic Oncology Group and Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. 5 Japanese Gynecologic Oncology Group and Department of Obstetrics and Gynecology, Tokyo Medical University, Tokyo, Japan. 6 Japanese Gynecologic Oncology Group and Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan. 7 Shanghai Gynecologic Oncology Group and Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. 8 Shanghai Gynecologic Oncology Group and Department of Gynecology and Obstetrics, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. 9 Shanghai Gynecologic Oncology Group and Department of Gynecology, Hunan Provincial People\'s Hospital, Changsha, China. 10 Shanghai Gynecologic Oncology Group and Department of Biostatistics, School of Public Health, Fudan University, Shanghai, China. 11 Shanghai Gynecologic Oncology Group and Clinical Statistics Center, Shanghai General Hospital, Shanghai, China. 12 Shanghai Gynecologic Oncology Group and Ovarian Cancer Program, Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China. xianglibing_123@sina.com. 13 Japanese Gynecologic Oncology Group and Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.)

出处: Journal of gynecologic oncology 2020 Vol.31 No.5 Pe86

关键词: Cytoreduction Surgical Procedures;Neoadjuvant Therapy;Ovarian Cancer.

摘要: Background: Two randomized phase III trials (EORTC55971 and CHORUS) showed similar progression-free and overall survival in primary or interval debulk ...

作者: Tong Wang, Bo Jing, Dongliang Xu, Yueling Liao, Hongyong Song, Beibei Sun, Wenzheng Guo, Jianhua Xu, Kaimi Li, Min Hu, Shuli Liu, Jing Ling, Yanbin Kuang, Tuo Zhang, Siwei Zhang, Feng Yao, Binhua P Zhou, Jiong Deng (Affiliations 1 Key Laboratory of Cell Differentiation and Apoptosis of Chinese Minister of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2 Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 3 Translational Medical Research Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. 4 Department of Pathology, Kunming Medical University, Kunming, Yunnan, China. 5 Department of Oral and Maxillofacial-Head and Neck Oncology, the Ninth People\'s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 6 Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 7 Department of Respiratory Medicine, The Second Affiliated Hospital, Dalian Medical University, Dalian, China. 8 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. 9 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. yaofeng6796678@126.com. 10 Department of Molecular and Cellular Biochemistry, Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, USA. peter.zhou@uky.edu. 11 Key Laboratory of Cell Differentiation and Apoptosis of Chinese Minister of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China. jiongdeng@shsmu.edu.cn. 12 Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China. jiongdeng@shsmu.edu.cn. 13 Translational Medical Research Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. jiongdeng@shsmu.edu.cn.)

出处: Oncogene 2020 Vol.39 No.15 P3179-3194

摘要: Chronic inflammation has been linked to promotion of tumorigenesis and metastasis in lung. However, due to lack of a relevant animal model for charact ...

作者: Ruizhi Hu;Zhixin Chen;Chen Dai;Xiang Guo;Wei Feng;Zhuang Liu;Han Lin;Yu Chen;Wu Rong (f Department of Orthopedics, The Second Affiliated Hospital, The Navy Medical University, Shanghai, 200003, China e Department of Ultrasound in Medicine, Shanghai East Hospital, Tongji University, Shanghai, 200120, China g Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China b Department of Ultrasound in Medicine, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200080, China a Department of Ultrasound in Medicine, Shanghai Tenth People\'s Hospital, Tongji University, Shanghai, 200072, China d State Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, China c School of Life Sciences, Shanghai University, Shanghai, 200444, China)

出处: Biomaterials 2020 P120455

关键词: Silicene;Radiotherapy;Photothermal therapy;Nanomedicine;Cancer

摘要: The rapid development of nanotechnology has triggered the emerging of tremendous theranostic nanoplatforms for combating cancers. Silicene, as an emer ...

作者: Yangbai Sun PhD;Renpeng Zhou PhD;Hao Zhang MD;Liu Rong MD;Wang Zhou PhD;Yimin Liang PhD;Qingfeng Li MD (6 Peking-Tsinghua Center for Life Sciences, Tsinghua University, Beijing, 100084, China 5 Department of Intensive Care Unit, Wuhan Leishenshan Hospital, Wuhan, 430101, China 7 Qiu-Jiang Bioinformatics Institute, Shanghai, 200003, China 2 null 1 Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China 4 Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China 3 Department of Bone Tumor Surgery, Changzheng Hospital of Second Military Medical University, Shanghai, 200003, China)

出处: Journal of the American Academy of Dermatology 2020

作者: Wenzheng Guo, Kaimi Li, Beibei Sun, Dongliang Xu, Lingfeng Tong, Huijing Yin, Yueling Liao, Hongyong Song, Tong Wang, Bo Jing, Min Hu, Shuli Liu, Yanbin Kuang, Jing Ling, Qi Li, Yadi Wu, Qi Wang, Feng Yao, Binhua P Zhou, Shu-Hai Lin, Jiong Deng (Affiliations 1 Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine. 2 Shanghai Jiao Tong University. 3 Translation Medicine Center, Shanghai Chest Hospital, Shanghai Jiao Tong University. 4 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine. 5 Pathophysiology, Shanghai Jiao Tong University School of Medicine. 6 Oncology, Fudan University Shanghai Cancer Center. 7 Department of Pathophysiology, Key laboratory of Cell Differentiation and Apoptosis of Minister of Education, Shanghai Jiao Tong University School of Medicine. 8 Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People\'s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine. 9 Department of Respiratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University. 10 Department of Oncology, Shanghai General Hospital, Shanghai Jiaotong University. 11 University of Kentucky Medical Center. 12 Respiratory Medicine, Second Affiliated Hospital of Dalian Medical University. 13 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai. 14 Molecular and Cellular Biochemistry, University of Kentucky School of Medicine. 15 State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University. 16 Pathophysiology, Shanghai Jiao Tong University School of Medicine jiongdeng@shsmu.edu.cn.)

出处: Cancer research 2020

摘要: Cancer cells need to generate large amounts of glutathione (GSH) to buffer oxidative stress during tumor development. A rate-limiting step for GSH bio ...

作者: Fang Wu, Feng Wang, Qian Yang, Yawen Zhang, Ke Cai, Lian Liu, Shuchun Li, YuanZheng Zheng, Jialing Zhang, Yiting Gui, Youhua Wang, Xu Wang, Yonghao Gui, Qiang Li (Affiliations 1 Translational Medical Center for Development and Disease, Institute of Pediatrics, Shanghai Key Laboratory of Birth Defect, Children\'s Hospital of Fudan University, Shanghai, 201102, China. 2 Cardiovascular Center, Children\'s Hospital of Fudan University, Shanghai, 201102, China. 3 Department of Neonatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201600, China. 4 Department of Emergency, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. 5 Department of Cardiology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. 6 Cancer Metabolism Laboratory, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. 7 Cardiovascular Center, Children\'s Hospital of Fudan University, Shanghai, 201102, China. yhgui@shmu.edu.cn. 8 Translational Medical Center for Development and Disease, Institute of Pediatrics, Shanghai Key Laboratory of Birth Defect, Children\'s Hospital of Fudan University, Shanghai, 201102, China. liq@fudan.edu.cn.)

出处: In vitro cellular & developmental biology. Animal 2020

关键词: Apoptosis;H9c2;Hyperglycemia;Myocardial injury;Proliferation;miRNA-23a-3p.

摘要: Maternal hyperglycemia potentially inhibits the development of the fetal heart by suppressing cardiomyocyte proliferation and promoting apoptosis. Dif ...

肿瘤临床医学中心简介

上海交通大学附属第一人民医院肿瘤科是上海市三甲综合医院中最早设立的肿瘤专科,是医院“十二五”期间重点发展的学科之一。2009年,医院整合肿瘤相关学科资源,成立了肿瘤中心,学科带头人黄倩教授,中心主任王理伟教授,肿瘤中心副主任王红霞(兼肿瘤科副主任[主持,南])、刘勇副主任医师,北部执行主任李琦主任医师。目前,肿瘤中心下设肿瘤内科、肿瘤放疗科、肿瘤介入科、肿瘤基因诊断及生物治疗科。目前肿瘤中心核定床位数185张,科室现有医技人员共50人,其中医生36人,正高级职称7人,副高级职称9人,中级职称18人,具有博士学历11人,硕士学历18人,博士研究生导师3人,硕士研究生导师5人;5人曾在国外进修学习,2人目前正在国外学习。肿瘤中心现为中国抗癌协会临床肿瘤学会(CSCO)执行委员会单位,CSCO胰腺癌专家委员会主任委员单位、CSCO抗肿瘤药物安全管理委员会委员单位、上海市抗癌协会理事单位、上海市医学会肿瘤专科委员会副主任委员单位、上海市肿瘤放射治疗专业委员会委员单位、上海市肿瘤化疗质控中心专家委员单位、上海市肿瘤放疗质控专家委员会单位。
2013年,经全院肿瘤相关专科共同努力,肿瘤中心入选国家临床重点专科建设项目,建设经费500万元。近3年,获得国家级课题(含国家自然科学基金重大研究计划、国家“973”“863”计划、重大国际合作)17项(仅2015年获得国家自然科学基金9项)、市级课题10项,各类科研经费2500余万元。在《Nature Medicine》、《Gastroenterology》等杂志发表高质量SCI论文。在胰腺癌的基础研究与临床诊治方面在上海市乃至全国颇具影响,主持编写了《胰腺癌患者健康教育手册》、中国首部《胰腺癌综合诊治中国专家共识》,为上海市胰腺疾病重点实验室及上海交通大学胰腺癌诊治中心。在人才培养方面,1人入选国家杰出青年基金计划、1人入选“百千万人才工程”国家级人选、1人入选上海市医学领军人才、1人入选上海市优秀学科带头人计划、3人入选上海市“浦江人才计划”。
2013年成立了肿瘤诊治中心以来,肿瘤学科得到迅猛发展。中心集肿瘤预防、诊断、综合治疗和康复为一体,能开展各项专科项目并形成如下医疗特色:
1.肿瘤个体化化疗、靶向治疗、免疫治疗:根据每位患者独特的基因表达情况,制定个体化的化疗方案,联合靶向治疗,极大提高了结直肠癌、肺癌、乳腺癌、胃癌等治疗效果。
2.精准放疗:目前拥有直线加速器3台,其中包括最先进的VARIAN-RapidArc治疗系统,实现了对实体肿瘤的精准放疗。现已开展三维适形放射治疗、调强适形放射治疗、图像引导下的三维适形调强放疗、同步放化疗、PET-CT引导下放疗、立体定向放射治疗等。
3.肿瘤微创治疗:在上海市开展了首例纳米刀治疗局部晚期胰腺癌,还包括高强度超声聚焦治疗系统(HIFU刀)、射频/微波肿瘤消融治疗系统、高频热疗系统、放射性粒子组织间植入治疗系统、氩氦刀低温冷冻肿瘤治疗系统、血管介入等技术,适用于治疗肝癌、肺癌等实体肿瘤。
4.肿瘤分子诊断:包括免疫功能检测、EGFR、K-ras、BRAF等基因突变检测,Her-2基因扩增检测,循环血肿瘤细胞检测等,为肿瘤患者个体化治疗与靶向治疗选择,以及预后判断,提供了更准确的方法。
5.开设肿瘤多学科联合诊治:多学科、多专家共同参与,为患者制定个体化、综合治疗方案,实现对每位肿瘤患者的全称管理,为肿瘤患者提供最科学的诊断治疗技术和最优质的一站式服务。
6.肿瘤生物治疗:全国率先开展生物免疫治疗与现有传统治疗手段(化疗、放疗)综合治疗实体肿瘤(胰腺癌、乳腺癌等),开展单病种肿瘤生物免疫治疗临床研究多项,通过规范病例入组,规范细胞制备与使用,规范疗效评价,并建立相应的疗效评估体系及规范。
7.新药临床研究:在医院药物临床研究机构的监督下,牵头、参与国际多中心临床研究,为结直肠癌、胰腺癌、乳腺癌、胃癌、肺癌等患者提供最新的药物治疗。
8.中心静脉置管及护理: 1999年我科成功置入上海市第一根PICC导管,开创了护士进 行中心静脉置管的新篇章。2006年引入PORT技术,2007年在全国率先开展非超声引导下塞丁格(MST)穿刺技术,2009年引入B超引导下置管技术,新技术的引进提高了PICC置管成功率,解决了临床实际问题。
目前,肿瘤中心的主要研究方向有:胰腺癌的临床及基础研究、胰腺癌炎-癌转化的基础研究、乳腺癌的基础与临床转化研究、三阴性乳腺癌的精准与免疫治疗研究、肿瘤放疗后再增殖研究、肺癌基础研究、转录因子对肝癌发生发展影响的机制研究、基因多态性与化疗敏感性的临床研究、血药浓度检测与化疗敏感性的临床研究等。"